8.26
price up icon2.23%   0.18
pre-market  Vorhandelsmarkt:  8.44   0.18   +2.18%
loading
Schlusskurs vom Vortag:
$8.08
Offen:
$8.08
24-Stunden-Volumen:
426.43K
Relative Volume:
0.85
Marktkapitalisierung:
$703.16M
Einnahmen:
$81.18M
Nettoeinkommen (Verlust:
$-80.94M
KGV:
-6.9947
EPS:
-1.1809
Netto-Cashflow:
$-55.15M
1W Leistung:
-3.17%
1M Leistung:
-2.25%
6M Leistung:
+66.20%
1J Leistung:
+118.52%
1-Tages-Spanne:
Value
$7.89
$8.315
1-Wochen-Bereich:
Value
$7.89
$8.70
52-Wochen-Spanne:
Value
$3.3691
$8.98

Sophia Genetics Sa Stock (SOPH) Company Profile

Name
Firmenname
Sophia Genetics Sa
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
415
Name
Twitter
Name
Nächster Verdiensttermin
2026-11-03
Name
Neueste SEC-Einreichungen
Name
SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, BTSG, TXG, HNGE

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SOPH icon
SOPH
Sophia Genetics Sa
8.26 703.16M 81.18M -80.94M -55.15M -1.1809
VEEV icon
VEEV
Veeva Systems Inc
274.84 44.50B 3.32B 941.65M 1.64B 5.6161
TEM icon
TEM
Tempus Ai Inc
82.24 14.93B 1.36B -302.91M -219.93M -1.7182
BTSG icon
BTSG
Brightspring Health Services Inc
56.02 11.08B 13.65B 169.86M 412.12M 1.0758
TXG icon
TXG
10 X Genomics Inc
84.11 10.96B 638.78M -22.66M 122.18M -0.1744
HNGE icon
HNGE
Hinge Health Inc
91.98 7.42B 646.34M -512.40M 202.76M -6.6871

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-18 Eingeleitet Craig Hallum Buy
2024-08-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-06-27 Eingeleitet Guggenheim Buy
2023-11-29 Eingeleitet RBC Capital Mkts Outperform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-01-03 Eingeleitet BTIG Research Buy
2022-11-23 Eingeleitet Credit Suisse Neutral
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-17 Eingeleitet Cowen Outperform
2021-08-17 Eingeleitet Credit Suisse Outperform
2021-08-17 Eingeleitet JP Morgan Overweight
2021-08-17 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

pulisher
Sep 22, 2026

SOPHiA GENETICS CEO Ross Muken Sells 422 Shares to Cover RSU Tax Withholding - Kalkine Media

Sep 22, 2026
pulisher
Sep 22, 2026

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - Eastern Progress

Sep 22, 2026
pulisher
Sep 21, 2026

Officer at SOPHiA GENETICS (NASDAQ: SOPH) lines up 774-share sale after 10b5-1 trades - Stock Titan

Sep 21, 2026
pulisher
Sep 21, 2026

Planned sale of 422 SOPHiA GENETICS (SOPH) shares disclosed under Rule 144 - Stock Titan

Sep 21, 2026
pulisher
Sep 21, 2026

SOPHiA GENETICS (SOPH) Insider Trading Activity 2026 - MarketBeat

Sep 21, 2026
pulisher
Sep 20, 2026

SOPHiA GENETICS SA(NasdaqGS: SOPH) added to S&P Global BMI Index - marketscreener.com

Sep 20, 2026
pulisher
Sep 18, 2026

SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? - finance.yahoo.com

Sep 18, 2026
pulisher
Sep 17, 2026

SOPHiA GENETICS (NASDAQ: SOPH) Insider Xu Zhenyu Retains 552,887 Shares Following Sale - Kalkine Media

Sep 17, 2026
pulisher
Sep 17, 2026

SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Menu Philippe Disposes of 5,000 Shares at $7.88 Each - Kalkine Media

Sep 17, 2026
pulisher
Sep 16, 2026

Chief Medical Officer Philippe Menu Sells 5,000 Shares of Sophia Genetics SA (SOPH) - GuruFocus

Sep 16, 2026
pulisher
Sep 16, 2026

SOPHiA GENETICS CSO Xu Zhenyu Sells 4,000 Shares Under Rule 10b5-1 Plan - Kalkine Media

Sep 16, 2026
pulisher
Sep 16, 2026

SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization Inflect - Seeking Alpha

Sep 16, 2026
pulisher
Sep 15, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Sep 15, 2026
pulisher
Sep 15, 2026

SOPHiA GENETICS Insider Van Well Daan Sells 6,168 Shares at $7.63 Each (NASDAQ: SOPH) - Kalkine Media

Sep 15, 2026
pulisher
Sep 14, 2026

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 8,500 Shares of Stock - MarketBeat

Sep 14, 2026
pulisher
Sep 11, 2026

Officer at SOPHiA GENETICS (NASDAQ: SOPH) to sell 6,168 shares - Stock Titan

Sep 11, 2026
pulisher
Sep 11, 2026

SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Sep 11, 2026
pulisher
Sep 10, 2026

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Director Sells $50,812.50 in Stock - MarketBeat

Sep 10, 2026
pulisher
Sep 10, 2026

SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares via 10b5-1 Trading Plan - Kalkine Media

Sep 10, 2026
pulisher
Sep 09, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 8.3%Time to Sell? - MarketBeat

Sep 09, 2026
pulisher
Sep 09, 2026

Maven Securities LTD Invests $866,000 in SOPHiA GENETICS SA $SOPH - MarketBeat

Sep 09, 2026
pulisher
Sep 04, 2026

SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise - Yahoo Finance

Sep 04, 2026
pulisher
Sep 02, 2026

SOPHiA GENETICS (NASDAQ:SOPH): Is Volume Signaling A Shift? - Kalkine Media

Sep 02, 2026
pulisher
Sep 01, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Sees Large Volume IncreaseHere's Why - marketbeat.com

Sep 01, 2026
pulisher
Aug 31, 2026

SOPHiA GENETICS CSO Zhenyu Xu Sells 10,000 Shares Under Rule 10b5-1 Plan - Kalkine Media

Aug 31, 2026
pulisher
Aug 31, 2026

Zhenyu Xu Sells 10,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Aug 31, 2026
pulisher
Aug 30, 2026

Sophia Genetics SA (SOPH) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 30, 2026
pulisher
Aug 28, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 5%Here's Why - MarketBeat

Aug 28, 2026
pulisher
Aug 27, 2026

Sophia Genetics SA (SOPH) Peer Comparison – Compare with Others - Value Research

Aug 27, 2026
pulisher
Aug 27, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer to sell 14K founder shares - Stock Titan

Aug 27, 2026
pulisher
Aug 26, 2026

SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares Under Rule 10b5-1 Plan - Kalkine Media

Aug 26, 2026
pulisher
Aug 26, 2026

SOPHiA GENETICS CTO Abhimanyu Verma Executes Sale of 10,000 Shares in August 2026 - Kalkine Media

Aug 26, 2026
pulisher
Aug 26, 2026

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CTO Sells $44,000.00 in Stock - MarketBeat

Aug 26, 2026
pulisher
Aug 25, 2026

SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale - Stock Titan

Aug 25, 2026
pulisher
Aug 21, 2026

SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media

Aug 21, 2026
pulisher
Aug 21, 2026

SOPHiA GENETICS CPO Manuela Valente Executes Share Option Exercise and Sale - Kalkine Media

Aug 21, 2026
pulisher
Aug 20, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan

Aug 20, 2026
pulisher
Aug 19, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView

Aug 19, 2026
pulisher
Aug 17, 2026

SOPHiA GENETICS SA (NASDAQ:SOPH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Aug 17, 2026
pulisher
Aug 16, 2026

SOPHiA Genetics Earnings Call Highlights Growth Push - TipRanks

Aug 16, 2026
pulisher
Aug 15, 2026

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript - AOL.com

Aug 15, 2026
pulisher
Aug 15, 2026

Sophia Genetics SA (SOPH) Chief Scientific Officer Zhenyu Xu Sel - GuruFocus

Aug 15, 2026
pulisher
Aug 15, 2026

SOPHiA GENETICS (SOPH) Slips 1.57% as Shares Consolidate Between Key Support and ResistanceStock Surge Alerts - vinanet.vn

Aug 15, 2026
pulisher
Aug 14, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock - MarketBeat

Aug 14, 2026
pulisher
Aug 13, 2026

SOPHiA GENETICS (SOPH) Slips 0.53% to $7.57 as Genomics AI Stock Consolidates Between Key LevelsSeasonality Effect - Vinanet

Aug 13, 2026
pulisher
Aug 13, 2026

SOPHiA GENETICS (SOPH) Consolidates at $7.57: Genomics Stock Poised Between Support and ResistanceCorrective Wave - vinanet.vn

Aug 13, 2026
pulisher
Aug 11, 2026

Sophia Genetics (SOPH) Executive Chairman Jurgi Camblong Sells 2 - GuruFocus

Aug 11, 2026

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$49.27
price down icon 0.07%
$48.66
price up icon 2.68%
$26.04
price down icon 1.99%
WAY WAY
$24.64
price down icon 0.48%
HQY HQY
$88.60
price down icon 1.98%
$91.98
price down icon 0.33%
Kapitalisierung:     |  Volumen (24h):